胚胎游离 DNA 与滋养层活检用于非整倍体检测:一致性率及临床意义。
Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications.
机构信息
R&D Department, Igenomix and Incliva, Valencia, Spain.
Genera, Center for Reproductive Medicine, Clinica Valle Giulia, Rome, Italy.
出版信息
Fertil Steril. 2019 Sep;112(3):510-519. doi: 10.1016/j.fertnstert.2019.04.038. Epub 2019 Jun 11.
OBJECTIVE
To study whether embryonic cell-free DNA (cfDNA) in spent blastocyst media is representative of the chromosomal constitution of a blastocyst.
DESIGN
Pilot prospective blinded study.
SETTING
In vitro fertilization center and genetics laboratory.
PATIENT(S): A total of 115 trophectoderm (TE) biopsies and spent blastocyst media (SBM) from 46 patients with ages ranging from 32 to 46 years, whose indications for preimplantation genetic testing of aneuploidy (PGT-A) were advanced maternal age, recurrent miscarriage, or recurrent implantation failure.
INTERVENTIONS(S): Spent blastocyst media collection and TE biopsy.
MAIN OUTCOME MEASURE(S): Concordance rates, sensitivity, and specificity between TE biopsies and SBM. Clinical outcomes in cases with euploid TE biopsies and euploid SBM compared with cases with euploid TE and aneuploid SBM.
RESULT(S): In general, the total concordance rate for ploidy and sex was 78.7%, and sensitivity and specificity were 94.5% and 71.7%, respectively. A significant increase for all parameters was observed for day 6/7 samples compared with day 5 samples, with day 6/7 samples showing total concordance for ploidy and sex of 84%, and sensitivity and specificity of 95.2% and 82.1%, respectively. Ongoing implantation rates in euploid TE/euploid SBM showed a threefold increase compared with euploid TE/aneuploid SBM (52.9% vs. 16.7%, respectively), without reaching significant differences. Interestingly, no miscarriages were observed when TE and SBM were euploidy concordant.
CONCLUSION(S): These results offer a better understanding of the dynamics of cfDNA during embryo development and despite more basic research being needed, they are reassuring to consider in the future this noninvasive approach as an alternative to TE biopsy for PGT-A.
目的
研究囊胚培养上清液中的胚胎无细胞游离 DNA(cfDNA)是否代表囊胚的染色体组成。
设计
前瞻性盲法研究。
地点
体外受精中心和遗传实验室。
患者
46 名年龄在 32 至 46 岁的患者的共 115 个滋养外胚层(TE)活检样本和囊胚培养上清液(SBM),这些患者进行植入前胚胎非整倍体检测(PGT-A)的指征为高龄、复发性流产或反复着床失败。
干预措施
囊胚培养上清液收集和 TE 活检。
主要观察指标
TE 活检与 SBM 的一致性率、灵敏度和特异性。具有整倍体 TE 活检和整倍体 SBM 的病例与具有整倍体 TE 和非整倍体 SBM 的病例的临床结局。
结果
一般来说,倍性和性别总一致性率为 78.7%,灵敏度和特异性分别为 94.5%和 71.7%。与第 5 天样本相比,第 6/7 天样本的所有参数均显著增加,第 6/7 天样本的总一致性率为 84%,灵敏度和特异性分别为 95.2%和 82.1%。整倍体 TE/整倍体 SBM 的持续着床率与整倍体 TE/非整倍体 SBM 相比增加了三倍(分别为 52.9%和 16.7%),但无显著差异。有趣的是,当 TE 和 SBM 均为整倍体时,没有发生流产。
结论
这些结果提供了对 cfDNA 在胚胎发育过程中的动态变化的更好理解,尽管需要更多的基础研究,但考虑将这种非侵入性方法作为 TE 活检的替代方法用于 PGT-A 是令人放心的。